Stem cells in the treatment of inflammatory arthritis (Q37781919)

23 August 2017

title

Stem cells in the treatment of inflammatory arthritis (English)

1 reference

mesenchymal stem cell transplantation

23 August 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20732653

21 June 2024

author name string

Alan Tyndall

1

1 reference

23 August 2017

Jacob M. van Laar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20732653

21 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20732653

21 June 2024

publication date

1 August 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1521694210000094?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

https://api.elsevier.com/content/article/PII:S1521694210000094?httpAccept=text/plain

21 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Best Practice & Research: Clinical Rheumatology

21 June 2024

published in

1 reference

23 August 2017

volume

24

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

565-574

1 reference

ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

21 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Stem cell transplantation for autoimmune disorders. Preclinical experiments

21 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation

21 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis

21 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration

21 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation

21 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Reduction of joint damage in severe rheumatoid arthritis by high-dose chemotherapy and autologous stem cell transplantation

21 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis

21 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation

21 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial

21 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007).

21 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Exercise tolerance in children with juvenile idiopathic arthritis after autologous SCT

21 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4 CD25 Foxp3 regulatory T cells

21 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study

21 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Decrease in synovial cellularity and cytokine expression after autologous stem cell transplantation in patients with juvenile idiopathic arthritis

21 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: Short-term efficacy correlates with reduction of macroscopic and histologic synovitis

21 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia

21 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis

21 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

21 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.

21 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Mesenchymal stem cells in health and disease

21 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

21 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

21 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice.

21 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

21 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

21 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

A Phase I Clinical Trial of the Treatment of Crohn's Fistula by Adipose Mesenchymal Stem Cell Transplantation

21 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study

21 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

21 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis

21 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans

21 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Cell therapy for age-related disorders: myocardial infarction and stroke--a mini-review.

21 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis

21 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis

21 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Establishment of nurse-like stromal cells from bone marrow of patients with rheumatoid arthritis: indication of characteristic bone marrow microenvironment in patients with rheumatoid arthritis

21 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level

21 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.BERH.2010.01.008

21 June 2024

Identifiers

1 reference

23 August 2017

1 reference